Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Wednesday is a Big Day for Dogecoin (DOGE) – A First Will Happen

Wednesday is a Big Day for Dogecoin (DOGE) – A First Will Happen

CryptoNewsNetCryptoNewsNet2025/09/15 18:03
By:en.bitcoinsistemi.com

Dogecoin is moving one step closer to Wall Street. The first-ever memecoin-focused exchange-traded fund (ETF) is set to launch.

The Dogecoin ETF (DOJE), developed by the REX Shares-Osprey partnership, may begin trading this week after weeks of delays.

The fund was expected to launch last week alongside Bonk (BONK), XRP, Bitcoin, and even Trump-themed ETFs. However, DOJE's launch didn't materialize. Bloomberg ETF analysts Eric Balchunas and James Seyffart pointed to Wednesday as a possible launch date but emphasized that there were no guarantees. “It seems more likely,” Seyffart said. “That's our base case scenario.”

If approved, DOJE would be the first ETF built on a memecoin in the U.S. While memecoins like Dogecoin, Shiba Inu (SHIB), and Bonk generally don't offer economic benefits, they are gaining popularity through internet culture, celebrity endorsements, and speculative trading.

Balchunas commented on this development in a post from his X account, saying, “For the first time in the US, an ETF containing an asset with no real use is coming.”

DOJE will not be a spot ETF. Instead of holding DOGE directly, it will offer investors indirect exposure through futures and derivatives through a subsidiary based in the Cayman Islands. This structure will eliminate the need for physical storage of the coin and give investors access to DOGE performance through traditional brokerage accounts.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Wall Street Stands Guard as Bessent Strikes Again: Aftereffects of August's "Treasury Turnaround" Persist, November Refinancing Notice Could Be the Next Flashpoint

As the US Treasury prepares to update its debt management plan in November, key clues may emerge on Friday.

智通财经•2026/10/16 01:06

"Coca-Cola belief" never goes out of style! KFC in America says goodbye to Pepsi and embraces Coca-Cola (KO.US); Buffett-style "boring investment" returns to the spotlight

KFC has chosen Coca-Cola as its soda supplier in the United States, abandoning its long-term partner Pepsi. As of the close of the U.S. stock market on Thursday, Coca-Cola's (KO.US) stock price reached a record high, defying the ongoing declines in global tech stocks, especially in the semiconductor and broad AI computing sectors.

智通财经•2026/10/16 01:06

AI financing concerns weigh heavily on chip stocks, global tech sector has lost over $1 trillion this week

Multiple pressures, including rising expectations of a Federal Reserve rate hike and increasing AI financing costs, have led to a massive sell-off in global tech stocks this week. The combined market value of the world's top 20 AI and semiconductor stocks has evaporated by more than $1 trillion, and the semiconductor ETF (SOXX) has recorded its longest losing streak in 11 years. On Thursday, SK Hynix continued to plunge by over 10% in a single day, while Nvidia, Samsung, and SoftBank were not spared.

华尔街见闻•2026/10/16 00:51

Safe Haven Amid AI Crash! Major Pharmaceutical Stocks Approach Historic Highs

Amid concerns over AI capital expenditures, funds are seeking a "certainty premium." State Street Healthcare ETF reached a record high. Eli Lilly and AbbVie are both approaching their historical highest closing prices, while Gilead and Amgen have surged 7.7% and 7.2% respectively over the past five days. Eli Lilly continues to bet on the future through its GLP-1 dominance and 40 M&A deals totaling $20 billion. AbbVie's core drug Skyrizi has shown positive data for its new subcutaneous formulation, which is expected to extend its patent and drive additional sales.

华尔街见闻•2026/10/16 00:37
Safe Haven Amid AI Crash! Major Pharmaceutical Stocks Approach Historic Highs